Category: Kaiser Health News

Workers Pay the Price While Congress and Employers Debate Need for Heat Regulations

Studies suggest official numbers vastly underestimate heat-related injuries and illness on the job. To institute protections, the government must calculate their cost — and the cost of inaction.

Mississippi’s Cervical Cancer Deaths Indicate Broader Health Care Problems

Mississippi has among the highest cervical cancer mortality rates in the U.S. When low-income women can’t afford regular preventive care, much less gynecological visits, this highly preventable and treatable cancer becomes a killer.

Biden Administration Proposes New Standards to Boost Nursing Home Staffing

The proposal would require major hiring at the most sparsely-staffed homes. But the proposal is already badly received by the nursing home industry which claims it can’t boost wages enough to attract workers.

Activist Misuses Federal Data to Make False Claim That Covid Vaccines Killed 676,000

Anti-vaccine tech entrepreneur Steve Kirsch, whose wild assertions have been repeatedly debunked, wrongly attributes deaths following vaccination to the vaccines themselves. The Centers for Disease Control and Prevention, which runs the database, calls that inaccurate and irresponsible.

When Temps Rise, So Do Medical Risks. Should Doctors and Nurses Talk More About Heat?

The medical dangers of heat are real. But people often ignore public heat alerts or don’t realize how vulnerable they are. A new alert system prompts clinicians to talk about heat with patients.

KFF Health News’ ‘What the Health?’: 3 Health Policy Experts You Should Know

In this special episode of KFF Health News’ “What the Health?” host Julie Rovner interviews three health policy experts.

How Far Will Montana’s Push to Remove Lead from School Drinking Water Go?

Montana has earmarked $3.7 million to address widespread high levels of lead in school drinking water. But it likely isn’t enough to solve the problem.

5 Things to Know About the New Drug Pricing Negotiations

The Biden administration unveiled the first 10 drugs subject to price negotiations, taking a swipe at the pharmaceutical industry. But what does it mean for patients?

A Move to Cut Drug Prices Has Patients With Rare Diseases Worried

A Colorado board has named five drugs it will review for affordability and potential cost caps. But patients with cystic fibrosis worry they will lose access to a life-changing therapy.

Artificial Intelligence May Influence Whether You Can Get Pain Medication

To contain the opioid crisis, health and law enforcement agencies have turned to technology to monitor doctor and patient prescription data. Experts have raised questions about how these systems work and worry about their accuracy and potential biases. Some patients and doctors say they’re being unfairly targeted.